Security key
405024100
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)
CUSIP: 405024100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, $.01 par value per share
- Shares outstanding
- 46,498,422
- Total 13F shares
- 54,253,774
- Share change
- +540,292
- Total reported value
- $4,048,407,950
- Put/Call ratio
- 25%
- Price per share
- $74.61
- Number of holders
- 297
- Value change
- +$51,089,014
- Number of buys
- 160
- Number of sells
- 150
Report period
Q2 2025
Institutions
297
Top holders
10
HAE full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 405024100
Recent filing periods:
Top shareholders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
4.6%
from 13D/G
|
2,624,879
|
$166,811,061 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
2,195,569
|
$139,529,000 | — | 31 Mar 2025 | |
| Capital Research Global Investors |
13F
13D/G
|
Company |
3.1%
from 13D/G
|
1,577,323
|
$100,238,877 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
14%
|
6,357,164
|
$403,997,772 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
5,099,621
|
$324,080,914 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
9.4%
|
4,348,362
|
$276,359,389 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
1,918,016
|
$121,889,917 | — | 31 Mar 2025 | |
| River Road Asset Management, LLC |
13F
|
Company |
3%
|
1,395,052
|
$88,655,555 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
1,221,367
|
$77,635,277 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
2.5%
|
1,161,296
|
$73,800,361 | — | 31 Mar 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
2.4%
|
1,118,331
|
$71,069,935 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
2.3%
|
1,075,604
|
$68,355,000 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.3%
|
1,063,702
|
$67,595,300 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
2.1%
|
966,167
|
$60,887,845 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
2.1%
|
965,184
|
$61,337,443 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
1.8%
|
843,256
|
$53,588,949 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.6%
|
734,543
|
$46,680,207 | — | 31 Mar 2025 | |
| SG Capital Management LLC |
13F
|
Company |
1.5%
|
719,432
|
$45,719,904 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.4%
|
651,418
|
$41,397,615 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
648,645
|
$41,221,390 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
643,232
|
$40,877,393 | — | 31 Mar 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.4%
|
632,016
|
$40,164,638 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
1.3%
|
625,565
|
$39,754,655 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
556,027
|
$35,335,516 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
554,644
|
$35,247,598 | — | 31 Mar 2025 | |
| Boston Partners |
13F
|
Company |
1.1%
|
531,431
|
$33,412,326 | — | 31 Mar 2025 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
1.1%
|
517,086
|
$32,860,815 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
512,010
|
$32,538,236 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
463,481
|
$29,454,224 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.93%
|
431,596
|
$27,428,030 | — | 31 Mar 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.92%
|
425,975
|
$27,070,711 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.91%
|
420,930
|
$26,750,092 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.89%
|
416,097
|
$26,442,965 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.86%
|
399,415
|
$25,382,823 | — | 31 Mar 2025 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.84%
|
391,861
|
$24,902,741 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.84%
|
390,856
|
$24,838,892 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.83%
|
385,604
|
$24,505,134 | — | 31 Mar 2025 | |
| SCHWARTZ INVESTMENT COUNSEL INC |
13F
|
Company |
0.81%
|
374,500
|
$23,799,475 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.8%
|
370,052
|
$23,516,773 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.77%
|
358,180
|
$22,762,339 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
357,182
|
$22,700,000 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.68%
|
316,542
|
$20,116,244 | — | 31 Mar 2025 | |
| LONDON CO OF VIRGINIA |
13F
|
Company |
0.59%
|
275,820
|
$17,528,382 | — | 31 Mar 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.58%
|
269,262
|
$17,111,600 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.5%
|
231,315
|
$14,700,068 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.48%
|
224,372
|
$14,258,841 | — | 31 Mar 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.45%
|
210,346
|
$13,367,488 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.42%
|
195,781
|
$12,442,000 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.4%
|
183,794
|
$11,680,109 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.38%
|
175,486
|
$11,152,154 | — | 31 Mar 2025 |
Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q2 2025
As of 30 Jun 2025,
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by
297 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,253,774 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, River Road Asset Management, LLC, T. Rowe Price Investment Management, Inc., ROYCE & ASSOCIATES LP, GEODE CAPITAL MANAGEMENT, LLC, and Capital Research Global Investors.
This page lists
298
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
313
Q2 2025 holders
297
Holder diff
-16
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.